Skip to main content

Table 1 Study outcomes

From: Effectiveness of a brief psychological mindfulness-based intervention for the treatment of depression in primary care: study protocol for a randomized controlled clinical trial

Instruments

Assessment Area

Time of assessmenta

Sociodemographic

Gender, age, marital status, education, occupation, economical level.

Screening

MINI

Psychiatric diagnosis

Screening

PHQ-9

Severity of depression

Screening, post-module, post-treatment and follow-ups

CSRI

Health and social services use

Screening and 12-month follow-up

BDI-II

Severity of depression

Baseline, post-treatment and follow-ups

SF-12

Health-related quality of life

Baseline, post-treatment and follow-ups

EQ-5D

Health-related quality of life

Baseline and follow-ups

PANAS

Positive and negative Affect

Baseline, post-modules and follow-ups

FFMQ

Facets and factors of mindfulness

Baseline and follow-ups

PHI

Remembered and experienced well-being

Baseline and follow-ups

ETS

Treatment expectations

Baseline

OTS

Treatment opinions

Post-treatment

  1. MINI Mini-International Neuropsychiatric Interview, PHQ-9 Patient Health Questionnaire-9, CSRI Client Service Receipt Inventory, BDI-II Beck Depression Inventory-II, SF-12 Short Form-12 Health Survey, EQ-5D EuroQoL-5D Questionnaire, PANAS Positive and Negative Affect Scale, FFMQ Five Facet Mindfulness Questionnaire, PHI Pemberton Happiness Index, ETS Expectation of Treatment Scale, OTS Opinion of Treatment Scale.
  2. aWaves: screening, baseline, post-treatment (6 weeks for the “face-to-face MBI + TAU” and “TAU alone” or 12 weeks after baseline for the “Internet-delivered MBI + TAU”), post-module (after each individual module for the “face-to-face MBI + TAU” and for the “Internet-delivered MBI + TAU”), follow-ups (both 6 and 12 month follow-up measurements)